First RSI close below 60 in 2013
RSI fell by another 6.4 points today to close at 55.7. It ends a remarkable five-week run where RSI closed every session in a very high range between 61.8 and 73.9.
I now see the stock as being in what should be a prolonged trading range from the high 25's to the high 27's. Generally when Pfizer rallies to the extent that it did between mid-November and the end of January, it spends the next three months or so doing very little additional on the upside.
However, with the stock now over 10% away from my revised one-year target price of $31, I am changing my long-term sentiment from hold back to buy.
Sentiment: Buy